Avadel Pharmaceuticals Plc's (NASDAQ:AVDL) Path To Profitability

Avadel Pharmaceuticals plc (NASDAQ:AVDL) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Avadel Pharmaceuticals plc operates as a

Simply Wall StJul 15 06:22 ET

Oppenheimer's Top SMID Ideas Within High-growth Themes

Seeking AlphaJul 10 12:46 ET

Avadel Pharmaceuticals to Join Russell 3000 Index

Globe NewswireJun 27 16:05 ET

Oppenheimer Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Maintains Target Price $29

Oppenheimer analyst Francois Brisebois maintains $Avadel Pharmaceuticals(AVDL.US)$ with a buy rating, and maintains the target price at $29.According to TipRanks data, the analyst has a success rate o

moomoo NewsJun 17 08:31 ET · Ratings

Rodman & Renshaw Initiates Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Announces Target Price $27

Rodman & Renshaw analyst Brandon Folkes initiates coverage on $Avadel Pharmaceuticals(AVDL.US)$ with a buy rating, and sets the target price at $27.According to TipRanks data, the analyst has a succes

moomoo NewsJun 11 17:31 ET · Ratings

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

European equities traded in the US as American depositary receipts were higher Wednesday morning, rising 0.93% to 1,436.34 on the S&P Europe Select ADR Index. From continental Europe, the gainers were

MT NewswiresJun 5 11:10 ET